CoChat

Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity

Open access
von Zimmermann, Claudia, Böhm, Lea, Richter-Schmidinger, Tanja, Kornhuber, Johannes, Lenz, Bernd, Mühle, Christiane · 2021 · Journal of Neural Transmission

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index; none of the 67 sources its claims cite is checked for support yet.

Abstract

Directly measuring hypothalamic pituitary adrenal (HPA) axis function, an important player in affective disorders, is intensive and invasive. A crucial component of this system, the activity of the glucocorticoid receptor (GR), can be assessed ex vivo instead. Here, we investigated GR sensitivity in patients with major depressive disorder (MDD) to determine its predictive potential. Psychometric data and blood samples were collected from patients experiencing a major depressive episode (MDE, n = 87), healthy control subjects (n = 49), and patients with remitted MDD (n = 31) at baseline and (for patients) after median 20 days of follow-up after treatment as usual. Blood cells were stimulated ex vivo with lipopolysaccharide and the effect was suppressed by increasing dexamethasone (DEX) concentrations. The resultant cytokine secretion profile (for IL-6, IL-10, and TNF-α) was considered indicative of GR activity. Higher baseline scores of the Montgomery–Åsberg Depression Rating Scale (MADRS) were associated with a stronger decrease of logIC IL-6 (indicating an increase of GR sensitivity). Higher baseline logEC IL-10 (indicating a lower GR sensitivity) and a stronger reduction of logEC IL-10 (indicating a stronger increase in GR sensitivity) were associated with a stronger decrease in the MADRS score. Patients with remitted MDD showed higher logIC TNF-α values (indicating lower GR sensitivity) in comparison to patients with a current MDD at baseline and follow-up. Initially low GR sensitivity measured ex vivo in peripheral blood cells that increases over the course of treatment could serve as a predictive marker for stronger improvement in depression severity.

Overview

CoChat Summary

TL;DR

In this ex vivo study, lower baseline glucocorticoid receptor sensitivity measured by logEC IL-10 and its increase over treatment predicted greater improvement in MADRS depression severity, while higher baseline MADRS predicted a stronger increase in GR sensitivity measured by logIC IL-6. Remitted MDD patients showed lower GR sensitivity via logIC TNF-α than currently depressed patients, but no baseline differences were found between current MDE and healthy controls.

Key findings

  • Among patients with current MDE, greater decrease in MADRS from baseline to follow-up correlated with higher baseline logEC IL-10 (ρ = −0.230, P = 0.036) and with a stronger reduction in logEC IL-10 over follow-up (ρ = 0.333, P = 0.003); higher baseline MADRS correlated with a stronger decrease in logIC IL-6 (ρ = −0.226, P = 0.046).
  • Patients with remitted MDD had higher logIC TNF-α (indicating lower GR sensitivity) than patients with current MDE at baseline (median 1.47 vs 1.35, P = 0.041) and at follow-up (P = 0.042).
  • Current MDE patients did not differ significantly from healthy controls in cytokine response, and logIC IL-6, logEC IL-10, and logIC TNF-α did not significantly change from baseline to follow-up in current MDE patients.
  • No significant correlations were found between GR sensitivity measures and BDI-II or HAMD scores.

Methods

  • CeraBiDe study; baseline sample included 87 patients with current MDE, 49 healthy controls, and 31 patients with remitted MDD; 84 of 87 current MDE patients were followed after median 20 days (IQR 15–27; range 14–43) on treatment as usual; complete logIC/EC values were available for 167 subjects at baseline and 79 at follow-up.
  • Whole blood was stimulated ex vivo with LPS 250 ng/ml and increasing dexamethasone concentrations (0 nM–100 µM), incubated 5.0 h at 37°C; IL-6, IL-10, and TNF-α were measured by ELISA, and logIC50 IL-6, logEC50 IL-10, and logIC50 TNF-α were calculated.
  • Non-parametric analyses were used because data were not normally distributed: Mann–Whitney U, Wilcoxon, Spearman correlations, and Chi-square tests; P < 0.05 was considered significant; depression severity was assessed with BDI-II, HAMD, MADRS, and SKID-I.

Limitations

  • Stated: associational design precludes causal conclusions; small sample and many excluded due to data quality control; no differentiation by episode duration, prior episodes, MDD subtype (e.g., anxious depression), or singular/recurrent episode; suicidal patients excluded; possible confounders (e.g., chronic fatigue syndrome, childhood trauma); many statistical tests raise false-positive risk; limited sample prevented sex-separate analyses; remitted MDD lacked follow-up, prior episode, and acute-episode HPA data.
  • Stated: lack of significant BDI-II/HAMD findings could be due to small sample size or scale sensitivity; heterogeneity may explain no overall baseline-to-follow-up change in GR sensitivity.
  • Evident from the text: treatment was naturalistic “treatment as usual” without controlling for treatment type or dose; the ex vivo peripheral blood assay is an indirect proxy for GR/HPA axis function rather than a direct HPA axis measurement.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s00702-020-02288-7

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 The change in absolute MADRS scores from baseline to follow-up was significantly negatively correlated with logEC IL-10 at baseline (a) and significantly positively with the change in logEC IL-10 (b). The graphs contain best-fit lines from regression analyses with 95% confidence intervals
Fig. 1 The change in absolute MADRS scores from baseline to follow-up was significantly negatively correlated with logEC IL-10 at baseline (a) and significantly positively with the change in logEC IL-10 (b). The graphs contain best-fit lines from regression analyses with 95% confidence intervalsCC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 1 Not valid · 39 Not checked · 49 Own results and interpretations

29 more claims

Create a free account to see all 89 claims and to verify the 66 references still open.

See all claims — free account
  • It may state two separate claims as one. 12
  • Probably not a substantial claim. 51

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Cited by

See all 13

Metadata

Authors
von Zimmermann, C., Böhm, L., Richter-Schmidinger, T., Kornhuber, J., Lenz, B., & Mühle, C.
Affiliations
Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
Corresponding author
von Zimmermann, Claudia
Venue
Journal of Neural Transmission
Published
2021-01
Volume
128
Issue
1
Pages
95-104
ISSN
  • 0300-9564 (ISSN-L)
  • 1435-1463
OpenAlex
W3120135266
Cited by
13
References
72
Citations by year
2026: 1 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 1
FWCI
1.07
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Neural Transmission (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
  • OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg) (submittedVersion, cc-by)
Funders
  • Bundesministerium für Bildung und Forschung (01EE1401C)
  • Deutsche Forschungsgemeinschaft (KO 947/13-1, 270949263/GRK2162)
  • Projekt DEAL
Topics
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
glucocorticoid receptor sensitivity, major depressive disorder, depression severity prediction, hypothalamic-pituitary-adrenal axis, IL-10, interleukin-6, TNF-α, lipopolysaccharide stimulation, dexamethasone, cytokine production, peripheral blood mononuclear cells, remitted depression, treatment response
MeSH terms
Depression, Major Depressive Disorder, Dexamethasone, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Pituitary-Adrenal System, Receptors, Glucocorticoid, Interleukin-10

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.